Gabriel Motoa

Prof. Gabriel Motoa

Internal Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2016 in Enfermedades Infecciosas y Microbiología Clínica
Verified
Journal Article
Open access
VBVictor M. Blanco
Victor M. Blanco
JMJuan J. Maya
Juan J. Maya
ACAdriana Correa
Adriana Correa
MPMarcela Perenguez
Marcela Perenguez
JMJuan S. Muñoz
Juan S. Muñoz
MVMaría Virginia Villegas
María Virginia Villegas
Urinary tract infections (UTI) are common in the community. However, information of resistant isolates in this context is limited in Latin America. This study aims to determine the prevalence and risk factors associated with community-onset UTI (CO-UTI) caused by extended-spectrum β-lactamase (ESBL)-Producing Escherichia coli in Colombia. A case-control study was conducted between August and December of 2011 in three Colombian tertiary-care institutions. All patients who were admitted to the Emergency Department with a probable diagnosis of CO-UTI were invited to participate. All participating patients were asked for a urine sample. ESBL confirmatory test, antibiotic susceptibility, and molecular epidemiology were performed in these E.coli isolates (Real Time-PCR for bla genes, repetitive element palindromic PCR [rep-PCR], multilocus sequence typing [MLST] and virulence factors by PCR). Clinical and epidemiological information was recorded, and a statistical analysis was performed. Of the 2124 recruited patients, 629 had a positive urine culture, 431 of which grew E.coli; 54 were positive for ESBL, of which 29 were CTX-M-15. The majority of ESBL isolates were susceptible to ertapenem, phosphomycin and amikacin. Complicated UTI was strongly associated with ESBL-producing E.coli infections (OR=3.89; 95%CI: 1.10-13.89; P=.03). CTX-M-15-producing E.coli showed 10 different pulsotypes, 65% were PT1 or PT4, and corresponded to ST131. Most of these isolates had 8 out of the 9 analysed virulence factors. E.coli harbouring blaCTX-M-15 associated with ST131 is still frequent in Colombia. The presence of complicated CO-UTI increases the risk of ESBL-producing E.coli, and must be taken into account in order to provide an adequate empirical therapy.

1 January 2017 in Revista Iberoamericana de Micologia
Verified
Journal Article
Closed access
GMGabriel Motoa
Gabriel Motoa
JMJuan Sebastián Muñoz
Juan Sebastián Muñoz
JGJose Millan Onate Gutierrez
Jose Millan Onate Gutierrez
CPChristian José Pallares
Christian José Pallares
CHCristhian Hernández
Cristhian Hernández
MVMaría Virginia Villegas
María Virginia Villegas

1 July 2016 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
LRLaura J. Rojas
Laura J. Rojas
MWMeredith S. Wright
Meredith S. Wright
ECElsa De La Cadena
Elsa De La Cadena
GMGabriel Motoa
Gabriel Motoa
KHKristine M. Hujer
Kristine M. Hujer
Robert BonomoRobert Bonomo
Robert Bonomo
We report complete genome sequences of four bla NDM-1 -harboring Gram-negative multidrug-resistant (MDR) isolates from Colombia. The bla NDM-1 genes were located on 193-kb Inc FIA, 178-kb Inc A/C2, and 47-kb (unknown Inc type) plasmids. Multilocus sequence typing (MLST) revealed that these isolates belong to sequence type 10 (ST10) ( Escherichia coli ), ST392 ( Klebsiella pneumoniae ), and ST322 and ST464 ( Acinetobacter baumannii and Acinetobacter nosocomialis , respectively). Our analysis identified that the Inc A/C2 plasmid in E. coli contained a novel complex transposon (Tn 125 and Tn 5393 with three copies of bla NDM-1 ) and a recombination “hot spot” for the acquisition of new resistance determinants.

9 August 2013 in Biomédica
Verified
Journal Article
Open access
PDF file
CHCristhian Hernández-Gómez
Cristhian Hernández-Gómez
VBVíctor M. Blanco
Víctor M. Blanco
GMGabriel Motoa
Gabriel Motoa
ACAdriana Correa
Adriana Correa
JMJuan José Maya
Juan José Maya
MVMaría Virginia Villegas
María Virginia Villegas
Evolución de la resistencia antimicrobiana de bacilos Gram negativos en unidades de cuidados intensivos en Colombia

29 April 2023 in Pathogens
Verified
Journal Article
Open access
PDF file
JCJorge L Cardenas-Alvarez
Jorge L Cardenas-Alvarez
GBGalit Balayla
Galit Balayla
ATAbel Triana
Abel Triana
RLRodrigo Diaz Lankenau
Rodrigo Diaz Lankenau
Carlos Franco-ParedesCarlos Franco-Paredes
Carlos Franco-Paredes
GMGabriel Motoa
Gabriel Motoa
(1) Background: Cryptogenic Klebsiella pneumoniae liver abscesses are an invasive infection with or without extra hepatic involvement in the absence of hepatobiliary disease or abdominal malignancy. Most of the evidence has emanated from reports from Asia, and previous studies in the Americas have limited clinical characterization. (2) Methods: To understand this syndrome’s characteristics on our continent, we conducted a scoping review to identify adult cases of idiopathic, community-acquired monomicrobial K. pneumoniae liver abscess in the Americas. (3) Results: We identified 144 cases spanning 1978–2022. Most cases were reported in males that had traveled or migrated from Southeast or East Asia with diabetes mellitus. Extrahepatic involvement and bacteremia were common, including seeding to the lungs, ocular structures, and central nervous system. Although limited by sample size, the most commonly reported genes were magA or rmpA. Concomitant percutaneous drainage and third generation cephalosporins (alone or in combination with other antibiotics) were frequently used, yet pooled fatality occurred in 9% of the reported cases. (4) Conclusions: The features of cryptogenic K. pneumoniae liver abscess in the Americas mirror those described in Asia, confirming its global dissemination. This condition is increasingly being reported in our continent and carries significant clinical impact due to its systemic invasiveness.

1 January 2020 in Therapeutic Advances in Infectious Disease
Verified
Journal Article
Open access
PDF file
GMGabriel Motoa
Gabriel Motoa
APAmy Pate
Amy Pate
DCDaniel Chastain
Daniel Chastain
SMSarah Mann
Sarah Mann
GCGregory S. Canfield
Gregory S. Canfield
Andrés Henao-MartinezAndrés Henao-Martinez
Andrés Henao-Martinez
A retrospective cohort study was performed that included adult patients with laboratory-confirmed CM treated at an academic tertiary hospital between January 2000 and September 2018. Those with a history of organ transplant or non-meningeal infections were excluded. Data were gathered on demographics, HIV status, clinical presentation, cerebrospinal fluid (CSF) profiles, neurological outcomes, hospital course, and mortality. A total of 70 patients with cryptococcal disease were identified. Our final sample included 36 CM patients, mean age was 48.8 ± 13.2 years; of this group, 66.7% (n = 24) had HIV. Median [interquartile range (IQR)] absolute CD4 count for the HIV group was 35 cells/μl (10–80 cells/μl). Non-HIV/non-transplant patients were significantly older (p < 0.001) and had higher rates of altered mental status (AMS) on presentation (58.3% versus 25%, p = 0.05). Non-HIV patients/non-transplant patients had significantly higher CSF white blood cell (WBC) count (p = 0.02), lower CSF glucose (p = 0.005), and higher CSF protein (p < 0.001) compared with HIV patients. There was no significant variation in temperature, blood pressure, WBC count, serum sodium, CSF opening pressure, length of stay, intensive care unit admission, or neurological outcomes. Overall, 90-day all-cause mortality was 19.4%: mortality rates were significantly higher in non-HIV/non-transplant patients at both 90 days (41.7% versus 8.3%, p = 0.017) and 1 year (41.7% versus 12.5%, p = 0.047). Compared with HIV-infected individuals, non-HIV/non-transplant CM patients have a higher CSF WBC count at the time of diagnosis, higher rates of AMS on presentation, and higher rates of 90-day and 1-year all-cause mortality. Further prospective research is needed to identify the hallmarks of CM in non-HIV/non-transplant patients to facilitate early identification and intervention.